Emmanuel Seront
Impact in
Papers in
- Oncology 39
- Cancer Immunotherapy and Biomarkers 19
-
- Renal cell carcinoma treatment 12
- Prostate Cancer Treatment and Research 8
- Co-authors
- Miikka Vikkula (16 shared papers)Laurence M. Boon (15 shared papers)An Van Damme (7 shared papers)Olivier Féron (7 shared papers)Angela Queisser (2 shared papers)Caroline Bouzin (3 shared papers)Jean‐Pascal Machiels (4 shared papers)Jennifer Hammer (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (5 papers)Frontiers in Oncology (4 papers)Orphanet Journal of Rare Diseases (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Emmanuel Seront
64 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 76
- Neurology 378
- Surgery 792
- Oncology 477
- Genetics 100
- Pathology and Forensic Medicine 158
Countries citing papers authored by Emmanuel Seront
This map shows the geographic impact of Emmanuel Seront's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Seront with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Seront more than expected).
Fields of papers citing papers by Emmanuel Seront
This network shows the impact of papers produced by Emmanuel Seront. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Seront. The network helps show where Emmanuel Seront may publish in the future.
Co-authors
The 25 scholars most cited alongside Emmanuel Seront, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 159 | |
| 2 | 2018 | 151 | |
| 3 | 2021 | 120 | |
| 4 | 2012 | 102 | |
| 5 | 2014 | 96 | |
| 6 | 2020 | 67 | |
| 7 | 2013 | 59 | |
| 8 | 2016 | 52 | |
| 9 | 2019 | 44 | |
| 10 | 2020 | 42 | |
| 11 | 2019 | 41 | |
| 12 | 2017 | 39 | |
| 13 | 2015 | 36 | |
| 14 | 2023 | 28 | |
| 15 | 2013 | 22 | |
| 16 | 2019 | 17 | |
| 17 | 2019 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2010 | 14 | |
| 20 | 2022 | 13 |
About Emmanuel Seront
Emmanuel Seront is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Neurology, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Vascular Malformations and Hemangiomas (14 papers), Vascular Malformations Diagnosis and Treatment (13 papers), Bladder and Urothelial Cancer Treatments (13 papers), Renal cell carcinoma treatment (12 papers), Urinary and Genital Oncology Studies (9 papers), Prostate Cancer Treatment and Research (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Neurology (378 citations), Surgery (792 citations), Oncology (477 citations), Genetics (100 citations) and Pathology and Forensic Medicine (158 citations). Emmanuel Seront has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Miikka Vikkula, Laurence M. Boon, An Van Damme, Olivier Féron, Angela Queisser, Caroline Bouzin, Jean‐Pascal Machiels, Jennifer Hammer, Sophie Dupont and Philippe Clapuyt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Frontiers in Oncology, Orphanet Journal of Rare Diseases and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.